Literature DB >> 9534245

Mycoplasma hominis expresses two variants of a cell-surface protein, one a lipoprotein, and one not.

Soren A Ladefoged, Gunna Christiansen.   

Abstract

A protein similar to the previously characterized variable surface-exposed membrane protein P120 was identified (P120'), establishing that Mycoplasma hominis PG21 possesses a novel gene family. The gene, p120', was sequenced and found to have some distinctive properties including a putative start codon of GTG, rather than the common ATG codon, and a coding region with a high G + C content, characteristic of essential housekeeping genes in mycoplasmas. No sequence homology was found to known proteins. The genomic locations of the p120 and p120' genes were determined on the restriction map of five M. hominis strains by PFGE. The genes were localized in two separate regions separated by more than 6 kb. Genes as well as proteins corresponding to P120' were identified in 24/24 M. hominis isolates tested and no size variation was detected. P120' had a molecular mass of 98 kDa, 20 kDa smaller than P120 as estimated by SDS-PAGE. The protein was surface-exposed and associated with the mycoplasma membrane, but had predominantly hydrophilic characteristics upon Triton X-114 extraction. The N-terminal part of P120' had a hydrophobic leader sequence without the characteristics of a prolipoprotein. This might explain the membrane association of the protein. Unlike P120, which is frequently recognized by sera of patients seropositive for M. hominis, P120' was only rarely recognized. The conserved nature of the P120 gene family indicates that it has an essential, although currently unknown, function.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9534245     DOI: 10.1099/00221287-144-3-761

Source DB:  PubMed          Journal:  Microbiology (Reading)        ISSN: 1350-0872            Impact factor:   2.777


  7 in total

1.  Topological analysis of Chlamydia trachomatis L2 outer membrane protein 2.

Authors:  P Mygind; G Christiansen; S Birkelund
Journal:  J Bacteriol       Date:  1998-11       Impact factor: 3.490

2.  Characterization of P40, a cytadhesin of Mycoplasma agalactiae.

Authors:  Bénédicte Fleury; Dominique Bergonier; Xavier Berthelot; Ernst Peterhans; Joachim Frey; Edy M Vilei
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

3.  A novel transposon construct expressing PhoA with potential for studying protein expression and translocation in Mycoplasma gallisepticum.

Authors:  Indu S Panicker; Anna Kanci; Chien-Ju Chiu; Paul D Veith; Michelle D Glew; Glenn F Browning; Philip F Markham
Journal:  BMC Microbiol       Date:  2012-07-08       Impact factor: 3.605

4.  Thymidine utilisation pathway is a novel phenotypic switch of Mycoplasma hominis.

Authors:  Gleb Yu Fisunov; Olga V Pobeguts; Valentina G Ladygina; Alexandr I Zubov; Mariya A Galyamina; Sergey I Kovalchuk; Rustam K Ziganshin; Daria V Evsyutina; Daria S Matyushkina; Ivan O Butenko; Olga N Bukato; Vladimir A Veselovsky; Tatiana A Semashko; Ksenia M Klimina; Galina A Levina; Olga I Barhatova; Irina V Rakovskaya
Journal:  J Med Microbiol       Date:  2022-01       Impact factor: 2.472

5.  The vaa locus of Mycoplasma hominis contains a divergent genetic islet encoding a putative membrane protein.

Authors:  Thomas Boesen; Jeppe Emmersen; Agata Baczynska; Svend Birkelund; Gunna Christiansen
Journal:  BMC Microbiol       Date:  2004-09-22       Impact factor: 3.605

6.  P80, the HinT interacting membrane protein, is a secreted antigen of Mycoplasma hominis.

Authors:  Miriam Hopfe; Ricarda Hoffmann; Birgit Henrich
Journal:  BMC Microbiol       Date:  2004-12-06       Impact factor: 3.605

7.  Genetic variability of the P120' surface protein gene of Mycoplasma hominis isolates recovered from Tunisian patients with uro-genital and infertility disorders.

Authors:  Boutheina Ben Abdelmoumen Mardassi; Hajer Ayari; Awatef Béjaoui-Khiari; Béhija Mlik; Imed Moalla; Faten Amouna
Journal:  BMC Infect Dis       Date:  2007-12-05       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.